Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26:3160–7.
Bonora E, Muggeo M, Post prandial blood glucose as a key factor for cardiovascular disease in type II diabetes: The epidemiologic evidence. Diabetologia 2001; 44: 2107-14.
Hanefeld M, Koehler C, Henkel E , et al. Post-challenge hyperglycemia related more strongly than fasting hyperglycemia with carotid intema media thickness: the RIAD Study. Diabet Med 2000; 7: 835-40.
Poster-Powell, Kaye. The Glycemic Index Guide. The glycemic index factor for people with diabetes. Hodder & Stroughtron Book; 1997: 74-93.
Ghosh JM. Trial of Low Glycemic Diet and Acarbose Therapy for Control of Post-prandial Hyperglycemia in Type 2 Diabetes Mellitus, Preliminary report. Int J Diab Dev Ctries [Internet]. 2005 [cited 2013 Jul 2];25(3). Available from: http://www.diabetes.org.in/ journal/2005_july-sept/original_article3.pdf.
Nattrass M, Lauritzen T. Review of prandial glucose regulation with repaglinide: a solution to the problem of hypoglycaemia in the treatment of Type 2 diabetes? Int J Obes Relat Metab Disord J Int Assoc Study Obes 2000; 24 Suppl 3:S21–31.
Okada K, Yagyu H, Kotani K, Yamazaki H, Ozaki K, Takahashi M, et al. Effects of miglitol versus sitagliptin on postprandial glucose and lipoprotein metabolism in patients with type 2 diabetes mellitus. Endocr J 2013; 60(7):913-22.
Holst JJ. Glucagon-like peptide-1: from extract to agent. The Claude Bernard Lecture, 2005. Diabetologia 2006; 49:253–60.
Singh J. RAPID ACTING INSULIN ANALOGUES. [cited 2013 Jul 5]; Available from: http:// apiindia.org/pdf/medicine_update_2012/ diabetology_05.pdf 66. Galli-Tsinopoulou A, Stergidou D. Insulin analogues for type 1 diabetes in children and adolescents. Drugs Today Barc Spain 1998. 2012 Dec;48(12):795–809.
Rosenfalck AM, Thorsby P, Kjems L, Birkeland K, Dejgaard A, Hanssen KF, et al. Improved postprandial glycaemic control with insulin Aspart in type 2 diabetic patients treated with insulin. Acta Diabetol 2000; 37:41–6.
เป็นยาที่ผู้ป่วยเอดส์มีความจำเป็นต้องใช้ เนื่องจากเป็นยาต้านไวรัสที่แนะนาให้เป็นสูตรแรก (First line regimen) ตามแนวทางการตรวจรักษาและป้องกันการติดเชื้อ HIV ของประเทศไทย
ช่วยลดปริมาณเชื้อ HIV ในร่างกายและทำให้ระบบภูมิคุ้มกันทำงานได้ดีขึ้น